13F
中

BMRN BIOMARIN PHARMACEUTICAL INC

2026Q1 · CUSIP 09061G101 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
552
Δ holders QoQ
+15
Breadth percentile
Top 21%
Whale holders
216
Δ whales
-7
Inst. holding value
$10.3B
New positions
90
Closed positions
75
Price momentum (1Q)
-17.1%
Put / Call
10/15

Breadth history (34 quarters)

2018Q1: Δ-6 · h=422 2018Q2: Δ+21 · h=443 2018Q3: Δ+8 · h=451 2018Q4: Δ+15 · h=466 2019Q1: Δ+12 · h=478 2019Q2: Δ-1 · h=477 2019Q3: Δ-41 · h=436 2019Q4: Δ+27 · h=463 2020Q1: Δ+30 · h=493 2020Q2: Δ+29 · h=522 2020Q3: Δ-34 · h=488 2020Q4: Δ+42 · h=530 2021Q1: Δ-4 · h=526 2021Q2: Δ-2 · h=524 2021Q3: Δ-21 · h=503 2021Q4: Δ+48 · h=551 2022Q1: Δ+1 · h=552 2022Q2: Δ-14 · h=538 2022Q3: Δ+11 · h=549 2022Q4: Δ+27 · h=576 2023Q1: Δ-27 · h=549 2023Q2: Δ+4 · h=553 2023Q3: Δ-38 · h=515 2023Q4: Δ+30 · h=545 2024Q1: Δ+7 · h=552 2024Q2: Δ+5 · h=557 2024Q3: Δ-6 · h=551 2024Q4: Δ-5 · h=546 2025Q1: Δ+41 · h=587 2025Q2: Δ-3 · h=584 2025Q3: Δ-7 · h=577 2025Q4: Δ-40 · h=537 2026Q1: Δ+15 · h=552 2018Q1: holders=422 2018Q2: holders=443 2018Q3: holders=451 2018Q4: holders=466 2019Q1: holders=478 2019Q2: holders=477 2019Q3: holders=436 2019Q4: holders=463 2020Q1: holders=493 2020Q2: holders=522 2020Q3: holders=488 2020Q4: holders=530 2021Q1: holders=526 2021Q2: holders=524 2021Q3: holders=503 2021Q4: holders=551 2022Q1: holders=552 2022Q2: holders=538 2022Q3: holders=549 2022Q4: holders=576 2023Q1: holders=549 2023Q2: holders=553 2023Q3: holders=515 2023Q4: holders=545 2024Q1: holders=552 2024Q2: holders=557 2024Q3: holders=551 2024Q4: holders=546 2025Q1: holders=587 2025Q2: holders=584 2025Q3: holders=577 2025Q4: holders=537 2026Q1: holders=552 -48 -24 +0 +24 +48 379498617 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 11 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 4% -3.5% -8.3%
2023Q4 Top 18% -12.6% +4.5%
2022Q4 Top 15% -14.0% -17.0%
2022Q3 Top 12% +26.2% +7.1%
2021Q4 Top 10% -15.7% +0.3%
2020Q4 Top 14% -8.9% -11.6%
2020Q2 Top 11% -35.1% -28.2%
2020Q1 Top 2% +25.3% -18.7%

Options Sentiment

Put holders
10
QoQ: -8
Call holders
15
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
42.2
EPS (TTM)
$1.39
EPS YoY
-48.5%
Revenue (TTM)
$3.2B
Revenue YoY
+9.9%
Quarterly Revenue & EPS (4Y)
2022-06-30: $534M 2022-09-30: $505M 2022-12-31: $538M 2023-03-31: $596M 2023-06-30: $595M 2023-09-30: $581M 2023-12-31: $646M 2024-03-31: $649M 2024-06-30: $712M 2024-09-30: $746M 2024-12-31: $747M 2025-03-31: $745M 2025-06-30: $825M 2025-09-30: $776M 2025-12-31: $875M 2026-03-31: $766M 2022-06-30: EPS 0.15 2022-09-30: EPS -0.04 2022-12-31: EPS 0.01 2023-03-31: EPS 0.27 2023-06-30: EPS 0.29 2023-09-30: EPS 0.21 2023-12-31: EPS 0.10 2024-03-31: EPS 0.46 2024-06-30: EPS 0.55 2024-09-30: EPS 0.55 2024-12-31: EPS 0.65 2025-03-31: EPS 0.95 2025-06-30: EPS 1.23 2025-09-30: EPS -0.16 2025-12-31: EPS -0.22 2026-03-31: EPS 0.54 0M 437M 875M $M -0.24 0.56 1.35 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 38 2023-03-31: PE 236.62023-06-30: PE 169.82023-09-30: PE 111.82023-12-31: PE 1022024-03-31: PE 73.22024-06-30: PE 67.82024-09-30: PE 38.22024-12-31: PE 29.32025-03-31: PE 222025-06-30: PE 172025-09-30: PE 20.52025-12-31: PE 33.32026-03-31: PE 37.3 15 132 248 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)